Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder

被引：0
|
作者：
Llewellyn Mills
Adrian Dunlop
Mark Montebello
Jan Copeland
Raimondo Bruno
Meryem Jefferies
Iain Mcgregor
Nicholas Lintzeris
机构：
[1] South East Sydney Local Health District,Drug and Alcohol Services
[2] University of Sydney,Specialty of Addiction Medicine, Faculty Medicine, and Health
[3] National Drug and Alcohol Research Centre,NSW Drug and Alcohol Clinical Research and Improvement Network (DACRIN)
[4] University of New South Wales,Drug and Alcohol Services
[5] NSW Health,Priority Research Centre for Brain and Mental Health, School of Medicine and Public Health
[6] Hunter New England Local Health District,Drug and Alcohol Services
[7] University of Newcastle,Mind and Neuroscience
[8] Northern Sydney Local Health District, Thompson Institute
[9] University of the Sunshine Coast,Drug Health
[10] University of Tasmania,School of Psychology
[11] Western Sydney Local Health District,Lambert Initiative Cannabinoid Therapeutics
[12] University Sydney,undefined
[13] University Sydney,undefined
来源：
Substance Abuse Treatment, Prevention, and Policy | / 17卷
关键词：
Cannabis use disorder; Cannabis dependence; Treatment outcomes; Treatment engagement;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Correlates of treatment engagement and client outcomes: results of a randomised controlled trial of nabiximols for the treatment of cannabis use disorder
    Mills, Llewellyn
    Dunlop, Adrian
    Montebello, Mark
    Copeland, Jan
    Bruno, Raimondo
    Jefferies, Meryem
    Mcgregor, Iain
    Lintzeris, Nicholas
    [J]. SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2022, 17 (01)
  • [2] FINDINGS OF A PLACEBO-CONTROLLED RANDOMISED CONTROLLED TRIAL OF NABIXIMOLS IN THE TREATMENT OF CANNABIS DEPENDENCE
    Lintzeris, Nicholas
    Allsop, David
    Bhardwaj, Anjali
    Mills, Llewellyn
    Dunlop, Adrian J.
    Copeland, Jan
    McGregor, Iain
    Bruno, Raimondo
    Gugusheff, Jessica
    Phung, Nghi
    Montebello, Mark
    Chan, Therese
    Kirby, Adrienne
    Hall, Michelle
    Jefferies, Meryem
    Luksza, Mary Jennifer
    Shanahan, Marian
    Kevin, Richard
    [J]. DRUG AND ALCOHOL REVIEW, 2018, 37 : S45 - S46
  • [3] EFFICACY OF NABIXIMOLS IN REDUCING FREQUENCY OF CANNABIS USE THREE MONTHS AFTER TREATMENT CESSATION: RESULTS FROM A RANDOMISED CONTROLLED TRIAL
    Lintzeris, Nicholas
    Mills, Llewellyn
    Dunlop, Adrian J.
    Copeland, Jan
    McGregor, Iain
    Bruno, Raimondo
    Gugusheff, Jessica
    Nghi Phung
    Montebello, Mark
    Chan, Therese
    Kirby, Adrienne
    Hall, Michelle
    Bhardwaj, Anjali
    Jefferies, Meryem
    Luksza, Jennifer
    Shanahan, Marian
    Kevin, Richard
    Allsop, David
    [J]. DRUG AND ALCOHOL REVIEW, 2019, 38 : S66 - S67
  • [4] Cannabis use in patients 3 months after ceasing nabiximols for the treatment of cannabis dependence: Results from a placebo-controlled randomised trial
    Lintzeris, Nicholas
    Mills, Llewellyn
    Dunlop, Adrian
    Copeland, Jan
    Mcgregor, Iain
    Bruno, Raimondo
    Kirby, Adrienne
    Montebello, Mark
    Hall, Michelle
    Jefferies, Meryem
    Kevin, Richard
    Bhardwaj, Anjali
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2020, 215
  • [5] A randomised controlled trial of cannabidiol for the treatment of cannabis use disorder: A study protocol
    Lintzeris, Nicholas
    Bhardwaj, Anjali
    Lubman, Dan I.
    Doyle, Michael
    Dunlop, Adrian J.
    Mills, Llewellyn
    Harrod, Mary E.
    Arunogiri, Shalini
    Malouf, Peter
    Haber, Paul S.
    Freeman, Tomp.
    Montebello, Mark E.
    Graham, Robert
    Childs, Steven
    Monds, Lauren A.
    Jeffries, Meryem
    Nean, Martin
    Ella, Stephen
    [J]. DRUG AND ALCOHOL REVIEW, 2023, 42 : S109 - S109
  • [6] Clinical Significance and Outcomes in Trial of Nabiximols for Treatment of Cannabis Dependence
    Levin, Frances R.
    Mariani, John J.
    [J]. JAMA INTERNAL MEDICINE, 2020, 180 (01) : 162 - +
  • [7] Nabiximols for the Treatment of Cannabis Dependence A Randomized Clinical Trial
    Lintzeris, Nicholas
    Bhardwaj, Anjali
    Mills, Llewellyn
    Dunlop, Adrian
    Copeland, Jan
    McGregor, Iain
    Bruno, Raimondo
    Gugusheff, Jessica
    Phung, Nghi
    Montebello, Mark
    Chan, Therese
    Kirby, Adrienne
    Hall, Michelle
    Jefferies, Meryem
    Luksza, Jennifer
    Shanahan, Marian
    Kevin, Richard
    Allsop, David
    Jago, Betty
    McKendrick, Lynsey
    Rivas, Consuelo
    Schwanz, Ricardo
    Yang, Abigail
    Zavareh, Zachary
    Hazelwood, Susan
    Hindson, Josephine
    Jackson, Melissa
    Keats, Julian
    Sadler, Craig
    Winmill, Anthony
    Barbaro, Angelo
    Black, Kerin
    Bowden, Pip
    Coreas, Jonathon
    Ho, Tim
    Nagubandi, Shyam
    Shahidi, Mahsa
    Silsbury, Catherine
    Snell, Lisa
    Wijanto, Matthew
    [J]. JAMA INTERNAL MEDICINE, 2019, 179 (09) : 1242 - 1253
  • [8] A randomized controlled trial to influence client language in substance use disorder treatment
    Moyers, Theresa B.
    Houck, Jon
    Glynn, Lisa H.
    Hallgren, Kevin A.
    Manuel, Jennifer K.
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2017, 172 : 43 - 50
  • [9] Varenicline as a treatment for cannabis use disorder: A placebo-controlled pilot trial
    McRae-Clark, Aimee L.
    Gray, Kevin M.
    Baker, Nathaniel L.
    Sherman, Brian J.
    Squeglia, Lindsay
    Sahlem, Gregory L.
    Wagner, Amanda
    Tomko, Rachel
    [J]. DRUG AND ALCOHOL DEPENDENCE, 2021, 229
  • [10] Effects of sub-chronic nabiximols on biological markers of individuals undergoing a clinical trial for the treatment of cannabis use disorder
    Wang, Ruoyu
    Trigo, Jose M.
    Le Foll, Bernard
    [J]. AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2023, 15 (08): : 5228 - 5238
12345